Not everyone is comfortable giving themselves shots, which makes oral GLP-1 medications an appealing alternative
Alongside the TRIUMPH-2 and TRIUMPH-3 results, Lilly confirmed it intends to submit a Biologics Licence Application to the FDA in the first quarter of 2027, and that chemistry, manufacturing and controls work is being completed to support the filing
However, being able to switch to 0.5mg of Wegovy will depend on your weight loss progress, tolerance of side effects, and will be subject to individual review by one of our clinicians
Side Effects to Expect During the Transition GI side effects are the most common adverse events with any GLP-1-class medication switch
The effectiveness of semaglutide can be influenced by various factors such as initial weight, insulin resistance, co-occurring medical conditions, and concurrent medications